GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Pro Medicus Ltd (OTCPK:PMCUF) » Definitions » Capex-to-Operating-Cash-Flow

Pro Medicus (Pro Medicus) Capex-to-Operating-Cash-Flow : 0.12 (As of Dec. 2023)


View and export this data going back to 2014. Start your Free Trial

What is Pro Medicus Capex-to-Operating-Cash-Flow?

Capex-to-Operating-Cash-Flow assesses how much of a company’s cash flow from operations is being devoted to capital expenditure. It’s also useful to distinguish whether the company is capital intensive or not.

Pro Medicus's Capital Expenditure for the six months ended in Dec. 2023 was $-2.34 Mil. Its Cash Flow from Operations for the six months ended in Dec. 2023 was $19.40 Mil.

Hence, Pro Medicus's Capex-to-Operating-Cash-Flow for the six months ended in Dec. 2023 was 0.12.


Pro Medicus Capex-to-Operating-Cash-Flow Historical Data

The historical data trend for Pro Medicus's Capex-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pro Medicus Capex-to-Operating-Cash-Flow Chart

Pro Medicus Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Capex-to-Operating-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.31 0.25 0.20 0.15 0.10

Pro Medicus Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Capex-to-Operating-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.16 0.13 0.17 0.07 0.12

Competitive Comparison of Pro Medicus's Capex-to-Operating-Cash-Flow

For the Health Information Services subindustry, Pro Medicus's Capex-to-Operating-Cash-Flow, along with its competitors' market caps and Capex-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pro Medicus's Capex-to-Operating-Cash-Flow Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Pro Medicus's Capex-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Pro Medicus's Capex-to-Operating-Cash-Flow falls into.



Pro Medicus Capex-to-Operating-Cash-Flow Calculation

Pro Medicus's Capex-to-Operating-Cash-Flow for the fiscal year that ended in Jun. 2023 is calculated as

Capex-to-Operating-Cash-Flow=- Capital Expenditure / Cash Flow from Operations
=- (-4.326) / 41.97
=0.10

Pro Medicus's Capex-to-Operating-Cash-Flow for the quarter that ended in Dec. 2023 is calculated as

Capex-to-Operating-Cash-Flow=- Capital Expenditure / Cash Flow from Operations
=- (-2.342) / 19.403
=0.12

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Pro Medicus  (OTCPK:PMCUF) Capex-to-Operating-Cash-Flow Explanation

Capex-to-Operating-Cash-Flow ratio assesses how much of a company’s Cash Flow from Operations is being devoted to Capital Expenditure. It is a good indicator in terms of how much the company is focused on growth. In general, a high Capex-to-Operating-Cash-Flow ratio indicates that the company is investing more in physical assets and is focused on growth and expansion. Conversely, lower ratio could indicate that a company has reached maturity and is no longer pursuing aggressive growth.

Moreover, the ratio is also useful to distinguish whether the company is capital intensive or not. If the ratio is large, then the company tends to be capital intensive. Lower ratio suggests that it’s a capital-light business. The ratio can be combined with ROIC % to identify whether the company is an asset-light business that has a high return on invested capital. This is one question investors commonly ask to see if a company qualifies as a good company.


Pro Medicus Capex-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Pro Medicus's Capex-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Pro Medicus (Pro Medicus) Business Description

Traded in Other Exchanges
Address
450 Swan Street, Richmond, Melbourne, VIC, AUS, 3121
Pro Medicus is a healthcare IT company specializing in radiology imaging software. Its main product, Visage 7, is a clinical desktop application that radiologists use to view, enhance, and manipulate images from any device and make a diagnosis. Its main customers are U.S. private academic hospitals. In fiscal 2022, Pro Medicus earned 79% of revenue in North America, 16% from Australia, and the remaining 6% in Europe.

Pro Medicus (Pro Medicus) Headlines

From GuruFocus

Visage Soars with CloudPACS at RSNA 2023

By PRNewswire 11-14-2023

Visage Signs New Agreement with NYU Langone Health

By PRNewswire PRNewswire 09-15-2020

Visage Signs Mercy for Visage 7 Open Archive

By PRNewswire PRNewswire 07-31-2018

Visage Signs Ludwig-Maximilians-Universit�t for PACS

By PRNewswire PRNewswire 10-16-2020

Visage 7 Named Best in KLAS 2023

By PRNewswire PRNewswire 02-08-2023

Visage Introduces Semantic Annotations for Visage 7

By PRNewswire PRNewswire 12-01-2019

Visage 7: Platform for the Future-Powered by Speed at RSNA 2019

By PRNewswire PRNewswire 11-15-2019

Proven Enterprise Imaging with Visage at RSNA 2018

By PRNewswire PRNewswire 11-14-2018

Enterprise Imaging Advances with Visage at SIIM 2019

By PRNewswire PRNewswire 06-20-2019

Visage Leads with CloudPACS at RSNA 2022

By PRNewswire PRNewswire 11-14-2022